Page last updated: 2024-10-28

haloperidol and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

haloperidol has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 2 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Searcy, E1
Choi, YC1
Lee, BI1
Huh, K1
Kim, GW1

Reviews

2 reviews available for haloperidol and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

ArticleYear
Helping the patient who has pervasive developmental disorder.
    JAAPA : official journal of the American Academy of Physician Assistants, 2001, Volume: 14, Issue:10

    Topics: Child; Child Development Disorders, Pervasive; Communication; Diagnosis, Differential; Haloperidol;

2001
RETT's syndrome in Korea--report of two cases.
    Yonsei medical journal, 1991, Volume: 32, Issue:2

    Topics: Child; Child Development; Female; Haloperidol; Humans; Korea; Rett Syndrome; Sex Factors

1991